Dr. Hua Xiong 熊华
Chief Physician, Associate Professor
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of common malignant tumors, with a focus on radiotherapy, chemotherapy, and molecular targeted therapy for lung cancer, breast cancer, cervical cancer, and bone and soft tissue tumors.
Dr. Xiong graduated from Tongji Medical College, Huazhong University of Science and Technology in 2004. From 2010 to 2013, Dr. Xiong completed postdoctoral research in oncology at the Hormel Institute, Mayo Clinic, USA. With over 10 years of clinical experience, Dr. Xiong has led or participated in seven National Natural Science Foundation and provincial-level projects, and published more than 20 papers, including 10 indexed by SCI.
Professional roles
- Member, Youth Committee, Hubei Anti-Cancer Association
- Member, Medical Oncology Professional Committee, Hubei Anti-Cancer Association
Name order: in Chinese the family name comes first (Xiong Hua). Papers usually list the name as Hua Xiong or Xiong H.
Selected publications
42 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Transl Lung Cancer Res, 2026 (senior author): Identification of prognostic biomarkers and immunotherapy response predictors in lung adenocarcinoma: integrative Mendelian randomization and machine learning analysis. PubMed 42170272
- Amino Acids, 2026 (senior author): Reprogramming of nitrogen metabolism in tumors: mechanisms and therapeutic implications. PubMed 41979669
- Transl Cancer Res, 2024 (senior author): Identification of risk factors of EGFR-TKIs primary resistance in lung adenocarcinoma patients and construction of a risk predictive model: a case-control study. PubMed 38737684
- Transl Cancer Res, 2024 (senior author): Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma. PubMed 38617509
- J Cancer, 2017 (first author): Twist1 Enhances Hypoxia Induced Radioresistance in Cervical Cancer Cells by Promoting Nuclear EGFR Localization. PubMed 28261334
- J Huazhong Univ Sci Technolog Med Sci, 2014 (senior author): Hypoxia-induced autophagy contributes to radioresistance via c-Jun-mediated Beclin1 expression in lung cancer cells. PubMed 25318890
- J Huazhong Univ Sci Technolog Med Sci, 2009 (first author): Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene. PubMed 19662370
- J Huazhong Univ Sci Technolog Med Sci, 2007 (first author): Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells. PubMed 17393113
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion